Amlexanox has multiple mechanisms of action
To address this, experts propose creating integrated chronic non-communicable disease (NCD) management clinics that combine weight management with the treatment of obesity-related conditions like diabetes and heart disease
Products are supplied in lyophilised form for stability
Adverse events that were reported in more than one patient in the treated groups were nausea (n = 2 in the tesamorelin 2 mg group, 11%), diarrhea (n = 2 in the tesamorelin 1 mg group, 11%), generalized weakness (n = 2 in the tesamorelin 1 mg group, 11%), fatigue (n = 2 in the tesamorelin 2 mg group, 11%), headache (n = 2 in the tesamorelin 2 mg group, 11%), upper respiratory tract infection (n = 2 in the tesamorelin 2 mg group, 11%), and light-headedness (n = 2 in the tesamorelin 1 mg group, 11%)
Mitochondrial dysfunction in aging: much progress but many unresolved questions